findmyKOL
Clinical trialNCT02533934CompletedPhase 4Interventional

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

SponsorUniversity of California, San FranciscoEnrollment68CirrhosisHIVHepatitis C
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Retrospective/Prospective, open-label study using sofosbuvir based DAA therapy to treat HIV/HCV coinfected pre or post liver transplant participants

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Francisco

    San Francisco, California, United States

  • Georgetown University

    Washington D.C., District of Columbia, United States

  • Johns Hopkins Medical Center

    Baltimore, Maryland, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, United States

  • Columbia University

    New York, New York, United States

  • Mt. Sinai Medical Center

    New York, New York, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Harvoni
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2016
Primary completion
31 Dec 2019
Completion
31 Dec 2019
Last update posted
2 Feb 2021
Registered enrollment
68
Registry id
NCT02533934

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.